Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 57801-57850 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06318962
Examining the Efficacy of a Digital Therapeutic to Prevent Suicidal Behaviors
NA
Recruiting
400 participants
Started: Feb 7, 2024 · Completed: Aug 1, 2027
3 conditions
1 sponsor
1 location
NCT06275607
Maladaptive Anger Treatment
NA
Recruiting
100 participants
Started: Feb 7, 2024 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT05969028
First Responder Airway & Compression Rate Trial
NA
Recruiting
4,200 participants
Started: Feb 7, 2024 · Completed: Mar 31, 2029
1 condition
1 sponsor
1 location
NCT06247735
Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.
PHASE2
Active, not recruiting
46 participants
Started: Feb 7, 2024 · Completed: Jun 30, 2026
1 condition
1 sponsor
38 locations
NCT05946382
A Comparison of Two Ultra-brief Interventions in Primary Care for Patients With Anxiety, Depression, and Stress.
NA
Active, not recruiting
124 participants
Started: Feb 7, 2024 · Completed: Dec 31, 2026
6 conditions
2 sponsors
1 location
NCT05969665
Effect of Monitoring Continuous Glucose Levels and Physical Activity Via Wearables on Cardiovascular Risk Factors
NA
Recruiting
100 participants
Started: Feb 7, 2024 · Completed: Aug 31, 2025
3 conditions
1 sponsor
1 location
NCT06021548
Biopsychosocial Markers of Addiction in Opioid Users: an Integrated Approach
N/A
Recruiting
350 participants
Started: Feb 7, 2024 · Completed: May 14, 2029
1 condition
1 sponsor
3 locations
NCT06379009
Effect of Home-based Training Program for Kidney Transplant Recipients (HOMETRAIN-KTR)
NA
Recruiting
200 participants
Started: Feb 7, 2024 · Completed: Jan 1, 2028
3 conditions
2 sponsors
1 location
NCT06916858
Prevalence of OSA and Diagnostic Accuracy of Type 3 Home Sleep Test in Difficult-to-treat Asthma
NA
Active, not recruiting
37 participants
Started: Feb 7, 2024 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT06785987
Continuous Lidocaine Infusion in Thyroid Surgery Using Intraoperative Neurophysiological Monitoring
PHASE4
Enrolling by invitation
100 participants
Started: Feb 7, 2024 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT06268444
Infant Sleep and Exposure to Mixture of Chemical Environmental Pollutants
NA
Recruiting
120 participants
Started: Feb 7, 2024 · Completed: Feb 28, 2026
3 conditions
1 sponsor
1 location
NCT04039490
Novel Device for Ultrasound-guided Pediatric Vessel Cannulations
NA
Recruiting
60 participants
Started: Feb 6, 2024 · Completed: Aug 31, 2025
1 condition
3 sponsors
1 location
NCT06236568
Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation
NA
Recruiting
40 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2030
2 conditions
1 sponsor
1 location
NCT06145919
Parent-Child Memory Study: Improving Future Thinking Among Mothers
NA
Recruiting
144 participants
Started: Feb 6, 2024 · Completed: Aug 31, 2025
1 condition
4 sponsors
1 location
NCT06062303
Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2
NA
Recruiting
180 participants
Started: Feb 6, 2024 · Completed: May 30, 2026
2 conditions
1 sponsor
1 location
NCT06262880
Dietary Supplementation on Gastrointestinal Barrier Function
NA
Recruiting
126 participants
Started: Feb 6, 2024 · Completed: Feb 6, 2025
1 condition
1 sponsor
1 location
NCT06158958
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid Tumors
PHASE1
Recruiting
192 participants
Started: Feb 6, 2024 · Completed: Jan 31, 2028
1 condition
1 sponsor
18 locations
NCT05995899
Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation
PHASE4
Active, not recruiting
30 participants
Started: Feb 6, 2024 · Completed: Oct 31, 2025
2 conditions
2 sponsors
1 location
NCT06243263
Postoperative Pain After Bupivacaine Supplementation in Mandibular Fracture Surgery
PHASE4
Recruiting
30 participants
Started: Feb 6, 2024 · Completed: Mar 4, 2024
4 conditions
1 sponsor
2 locations
NCT06252285
Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers
PHASE3
Active, not recruiting
6,300 participants
Started: Feb 6, 2024 · Completed: Dec 7, 2027
1 condition
1 sponsor
130 locations
NCT06341634
Surveillance of Suicide Ideation in Adolescents (VISIA)
N/A
Enrolling by invitation
339 participants
Started: Feb 6, 2024 · Completed: Sep 30, 2025
4 conditions
5 sponsors
4 locations
NCT05943665
MDMA for AUD/PTSD Comorbidity
PHASE2
Recruiting
18 participants
Started: Feb 6, 2024 · Completed: Jan 30, 2026
2 conditions
1 sponsor
1 location
NCT06259279
High Impact Training to Patients with Prostate Cancer and Bone Metastases
NA
Recruiting
102 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06102330
Multicenter HomeVENT: Home Values and Experiences Navigation Track
NA
Recruiting
600 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2030
3 conditions
2 sponsors
4 locations
NCT06248684
Prevention of Postoperative Delirium in Elderly Patients
NA
Not yet recruiting
15,000 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
0 locations
NCT06273761
Evaluation of Medication Management Service
NA
Recruiting
640 participants
Started: Feb 6, 2024 · Completed: May 1, 2027
6 conditions
10 sponsors
8 locations
NCT06225973
A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease
PHASE2
Active, not recruiting
880 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2024
1 condition
1 sponsor
18 locations
NCT06247345
A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01
PHASE1
Recruiting
73 participants
Started: Feb 6, 2024 · Completed: Feb 28, 2026
1 condition
2 sponsors
4 locations
NCT06152185
Mindfulness App Training for Cardiovascular Health
NA
Recruiting
105 participants
Started: Feb 6, 2024 · Completed: Apr 30, 2026
2 conditions
2 sponsors
1 location
NCT06859489
Active aGeing And Personalised Service's Ecosystem (AGAPE) Aims to Implement an Advanced Technology Platform That Provides Services to the Elderly, Formal and Informal Caregivers, and Caregiving Organizations
NA
Active, not recruiting
68 participants
Started: Feb 6, 2024 · Completed: Mar 31, 2025
2 conditions
7 sponsors
1 location
NCT06777771
Effects of Reformer Pilates in Pregnant Women
NA
Recruiting
30 participants
Started: Feb 6, 2024 · Completed: Sep 30, 2025
5 conditions
1 sponsor
1 location
NCT06883942
Pilot Study on the Evaluation of the Functionality, Safety and Reliability of New Tripping Devices for Lower Limbs.
N/A
Recruiting
30 participants
Started: Feb 6, 2024 · Completed: Jun 30, 2025
3 conditions
2 sponsors
1 location
NCT06751121
Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori
PHASE3
Recruiting
460 participants
Started: Feb 6, 2024 · Completed: Jun 30, 2026
3 conditions
2 sponsors
1 location
NCT06277245
A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.
PHASE3
Active, not recruiting
354 participants
Started: Feb 6, 2024 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT06586021
Evaluation of the Aortoseal™ for Sealing and Fixation of AAA Endovascular Grafts to Aortic Wall
NA
Recruiting
25 participants
Started: Feb 6, 2024 · Completed: Nov 1, 2029
1 condition
1 sponsor
1 location
NCT06214741
A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight
PHASE3
Active, not recruiting
307 participants
Started: Feb 6, 2024 · Completed: Jan 30, 2026
2 conditions
1 sponsor
28 locations
NCT06262438
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
PHASE2
Recruiting
60 participants
Started: Feb 6, 2024 · Completed: Jun 30, 2032
1 condition
2 sponsors
1 location
NCT06525168
Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on DA414
PHASE1
Recruiting
82 participants
Started: Feb 6, 2024 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT05868629
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
N/A
Recruiting
40 participants
Started: Feb 6, 2024 · Completed: May 4, 2028
1 condition
1 sponsor
6 locations
NCT06246110
A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC
PHASE2
Recruiting
70 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2027
1 condition
1 sponsor
39 locations
NCT06395922
Blockbuster LMA Versus Baska Mask in Laparoscopic Cholecystectomy
NA
Recruiting
140 participants
Started: Feb 6, 2024 · Completed: Jun 1, 2024
3 conditions
1 sponsor
1 location
NCT06259513
Omission of Axillary Surgery in Breast Cancer Patients
NA
Recruiting
350 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2033
3 conditions
1 sponsor
1 location
NCT06238544
Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria
PHASE2
Recruiting
120 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2027
1 condition
1 sponsor
2 locations
NCT05542069
Measurement of the Diaphragm Loading During the Training With a IMT Device
N/A
Recruiting
10 participants
Started: Feb 6, 2024 · Completed: Mar 30, 2025
1 condition
1 sponsor
1 location
NCT06992986
Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy Counterparts in Adult Male Population
N/A
Recruiting
50 participants
Started: Feb 6, 2024 · Completed: Jul 6, 2025
1 condition
1 sponsor
1 location
NCT06224933
Augmented Reality For MRI-Guided Interventions
NA
Recruiting
25 participants
Started: Feb 6, 2024 · Completed: May 31, 2026
3 conditions
1 sponsor
1 location
NCT06225726
Elastographic Analysis of Urothelial Bladder Tumours
N/A
Recruiting
50 participants
Started: Feb 6, 2024 · Completed: Feb 28, 2025
2 conditions
1 sponsor
1 location
NCT06246942
Physiology of Human Brain Connectivity
NA
Not yet recruiting
80 participants
Started: Feb 6, 2024 · Completed: Apr 15, 2027
1 condition
2 sponsors
0 locations
NCT06169722
TDI01 Suspension in the Treatment of Chronic Graft-versus-host Disease (cGVHD))
PHASE1/PHASE2
Active, not recruiting
60 participants
Started: Feb 6, 2024 · Completed: Aug 31, 2027
1 condition
1 sponsor
1 location
NCT06377267
Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial)
PHASE2
Recruiting
100 participants
Started: Feb 6, 2024 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
Previous
1
More pages
1154
1155
1156
1157
1158
1159
1160
More pages
2369
Next